--2025/Q1-- / 14.259B--
--2024/Q4-- / 17.154B--
Oct 29, 20242024/Q317.702B / 14.865B--
Jul 30, 20242024/Q213.283B / 13.019B--
May 1, 20242024/Q114.879B / 13.923B--
US Stock MarketDetailed Quotes
PFE Pfizer
- 25.890
- -0.540-2.04%
Close Dec 18 16:00 ET
- 25.790
- -0.100-0.39%
Pre 05:18 ET
146.72BMarket Cap34.52P/E (TTM)
26.520High25.860Low47.58MVolume26.190Open26.430Pre Close1.24BTurnover0.84%Turnover Ratio69.97P/E (Static)5.67BShares31.05752wk High1.59P/B146.50BFloat Cap24.10552wk Low1.67Dividend TTM5.66BShs Float53.878Historical High6.45%Div YieldTTM2.50%Amplitude5.393Historical Low26.126Avg Price1Lot Size
Pfizer Key Stats
Pfizer Q3 2024 Earnings Date
Overview | Pfizer exceeds Q3 expectations, further raises FY2024 outlook
Currency：USDOct 29, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 14.87B | 17.70B | +2.84B |
| Beat Est. | +12.34% | +31.21% | +19.08% |
| EPS | 0.30 | 0.78 | +0.48 |
| Beat Est. | +171.23% | +285.71% | +160.78% |
Analyst Rating
Dec 18, 2024
Pfizer Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Pfizer Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Price
% Chg
No Data
